Post provided by Dr. Beule’s colleagues at Tibotec.
In memoriam: Karel De Beule, PharmD, MBA (July 8, 1958 – April 6, 2010) following an outstanding 24+ year career in the pharmaceutical industry; Karel will be remembered for his contributions to pharmaceutical development in the infectious disease area, starting with the Janssen Pharmaceutica antifungal portfolio, which included itraconazole in the 1980-90’s, followed by his involvement from 2004 to 2010 with the novel TB drug, TMC 207, as compound development team leader at Tibotec. He was instrumental in establishing the landmark collaboration between Tibotec and the TB Alliance to accelerate TB drug development.
His unwavering dedication to the TB field will be remembered and sorely missed.